Sort
48,018 grants matching “immunotherapy”
Broad spectrum therapeutics targeting resolvase enzymes
$1,012,363Frederic D Bushman · University Of Pennsylvania · U01 · FY2009 · AI
Clinical Studies for Improving Survival Rates for Oral Cancer Patients in Low Resource Settings
$1,012,303Manijeh N Goldberg · Privo Technologies, Llc · R44 · FY2024 · CA
Comprehensive Assessment of Cancer Immunotherapy Response
$1,012,057Timothy Perk · Aiq Solutions, Inc. · R44 · FY2022 · CA
A Rational Systematic Approach to Find Combinations of Pharmacologic and Immune Therapies that Target Identifiable Oncogenic States
$1,011,983Pablo Tamayo · University Of California, San Diego · U01 · FY2017 · CA
A Phase II Trial of Rituximab In Myasthenia Gravis
$1,011,907Richard Nowak · Yale University · U01 · FY2015 · NS
Humanization, Production, and PK/PD Characterization of anti-TIP1 antibody against Non-Small Cell Lung Cancer
$1,011,611Sapna Deore · Medical Guidance Systems, Llc · R44 · FY2019 · CA
Humanized Mouse Avatars for T1D
$1,011,466Dale L Greiner · Univ Of Massachusetts Med Sch Worcester · U01 · FY2020 · DK
CELL THERAPY CORE
$1,010,803Michael I Nishimura · Loyola University Chicago · P01 · FY2013 · CA
Integrating targeted and immunotherapy to treat genetically heterogeneous cancers
$1,010,431William A Weiss · University Of California, San Francisco · U01 · FY2021 · CA
Integrating targeted and immunotherapy to treat genetically heterogeneous cancers
$1,010,431William A Weiss · University Of California, San Francisco · U01 · FY2020 · CA
Integrating targeted and immunotherapy to treat genetically heterogeneous cancers
$1,010,431William A Weiss · University Of California, San Francisco · U01 · FY2018 · CA
Leadership, Planning and Evaluation
$1,010,352Alan Ashworth · University Of California, San Francisco · P30 · FY2025 · CA
Stem Cell Biology, Cancer Stem Cell Biology, and Cancer Immunotherapy
$1,010,214Irving Lerner Weissman · Stanford University · R35 · FY2018 · CA
Molecular Mechanisms and Treatment Of Autoimmunity In Man And Animal Models
$1,010,176Michael J Lenardo · National Institute Of Allergy And Infectious Diseases · ZIA · FY2017 · AI
Searching for the Goldilocks Zone of Innate Immunity in Alzheimer's Disease
$1,010,081Todd E. Golde · Emory University · R01 · FY2024 · AG
Development
$1,010,066Ana M Navarro · University Of California, San Diego · U54 · FY2010 · CA
Tissue Processing-Sequencing Facility
$1,009,707Cathy D Vocke · Division Of Basic Sciences - Nci · ZIC · FY2019 · CA
Los Angeles Pediatric AIDS Clinical Trials Unit
$1,009,613University Of California Los Angeles · U01 · FY2003 · AI
Nanosystems Biology Cancer Center
$1,009,425James R. Heath · California Institute Of Technology · U54 · FY2017 · CA
Monitoring Immunotherapy Response via Gene Silencing Landscapes in Cell-Free DNA
$1,009,228Michael T Barrett · Binary Genomics, Inc. · R44 · FY2025 · CA
Vaccine Studies of Simian Immunodeficiency Virus (SIV) in Macaques
$1,009,129Vanessa M. Hirsch · National Institute Of Allergy And Infectious Diseases · ZIA · FY2016 · AI
Autoimmunity: Mechanisms of Unresponsiveness
$1,009,020Charles Garrison Fathman · Stanford University · P01 · FY2008 · AI
Understanding and Mimicking TCR Recognition with Therapeutic Monoclonal Antibodies.
$1,008,900David A Scheinberg · Sloan-Kettering Inst Can Research · R35 · FY2024 · CA
Development of synthetic sphingolipids for prostate cancer therapy
$1,008,833Daniel Gil · Siege Pharmaceuticals, Inc. · R44 · FY2020 · CA
Humanized Mouse Avatars for T1D
$1,008,786Dale L Greiner · Univ Of Massachusetts Med Sch Worcester · U01 · FY2021 · DK